Y.-H. Ling
- Co-authors
- Waldemar PriebeRomán Pérez-SolerKenneth L. BeattieJay A. NelsonJenny ChanBilal PiperdiTianhong LiGlenn S. Kroog
- Topics
- HER2/EGFR in Cancer Research (7 papers)Colorectal Cancer Treatments and Studies (4 papers)Cancer Treatment and Pharmacology (4 papers)
- Cited by
- ToxicologyOncologyMolecular Biology
- Journals
- Journal of Clinical OncologyJNCI Journal of the National Cancer InstituteJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Y.-H. Ling
24 papers receiving 568 citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 333
- Oncology 226
- Pulmonary and Respiratory Medicine 84
- Genetics 57
- Organic Chemistry 46
Countries citing papers authored by Y.-H. Ling
This map shows the geographic impact of Y.-H. Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y.-H. Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y.-H. Ling more than expected).
Fields of papers citing papers by Y.-H. Ling
This network shows the impact of papers produced by Y.-H. Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y.-H. Ling. The network helps show where Y.-H. Ling may publish in the future.
Co-authorship network of co-authors of Y.-H. Ling
This figure shows the co-authorship network connecting the top 25 collaborators of Y.-H. Ling. A scholar is included among the top collaborators of Y.-H. Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y.-H. Ling. Y.-H. Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 10 | |
| 4 | 13 | |
| 5 | 22 | |
| 6 | 29 | |
| 7 | 3 | |
| 8 | 10 | |
| 9 | 11 | |
| 10 | 27 | |
| 11 | EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity. | 11 |
| 12 | 58 | |
| 13 | 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells. | 42 |
| 14 | 8 | |
| 15 | In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes. | 33 |
| 16 | Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. | 160 |
| 17 | 54 | |
| 18 | 28 | |
| 19 | 17 | |
| 20 | 3 |
About Y.-H. Ling
Y.-H. Ling is a scholar working on Oncology, Toxicology and Biochemistry, having authored 24 papers that have together received 582 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Toxicology (31 citations), Oncology (226 citations) and Molecular Biology (333 citations). Y.-H. Ling has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Waldemar Priebe, Román Pérez-Soler, Kenneth L. Beattie, Jay A. Nelson, Jenny Chan, Bilal Piperdi, Tianhong Li, Glenn S. Kroog, Gang Zong and Waun Ki Hong. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.